Skip to main content
. 2021 Jul 23;15(3):78. doi: 10.3892/br.2021.1454

Table II.

Genotype and allele frequencies of IL-6 and TNF-α gene polymorphisms in the 200 patients with IS and the 200 control individuals, and their associations with the risk of IS susceptibility.

A, IL-6-174G/C
Polymorphism IS patients, n (%) Controls, n (%) P-valueb OR (95% CI) P-valuec
Genotype          
     GG 190 (95.0) 188 (94.0) 0.959 1.000  
     GC 10 (5.0) 12 (6.0) 0.832 0.825 (0.348-1.955) 0.661
     CC 0 (0.0) 0 (0.0)      
Allele          
     G 390 (97.5) 388 (97.0) 0.971 1.000  
     C 10 (2.5) 12 (3.0) 0.832 0.829 (0.354-1.941) 0.666
     MAF (%) 2.5 3.0      
B, TNF-α-308G/A
Genotype          
     GG 166 (83.0) 181 (92.1) 0.452 1.000  
     GA 31 (15.5) 19 (7.9) 0.119 1.747 (0.951-3.211) 0.072
     AA 3 (1.5) 0 (0.0) 0.250    
     GA+AA 34 (17.0) 19 (7.9) 0.053 1.951 (1.071-3.554) 0.029a
Allele          
     G 363 (90.7) 381 (95.2) 0.533 1.000  
     A 37 (9.3) 19 (4.8) 0.022a 2.044 (1.154-3.620) 0.014a
     MAF (%) 9.3 4.8      

aP<0.05.

bCalculated using a binomial test.

cCalculated using multivariate logistic regression. OR (95% CI) were calculated using a multivariate logistic regression model. IS, ischemic stroke; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval.